There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Palatin Technologies (PTN – Research Report) and Avrobio (AVRO – Research Report) with bullish sentiments.
Palatin Technologies (PTN)
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Palatin Technologies today and set a price target of $5.00. The company’s shares closed last Tuesday at $0.40, close to its 52-week low of $0.32.
According to TipRanks.com, Pantginis has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Currently, the analyst consensus on Palatin Technologies is a Moderate Buy with an average price target of $3.50.
See today’s best-performing stocks on TipRanks >>
Avrobio (AVRO)
In a report released today, Gil Blum from Needham reiterated a Buy rating on Avrobio, with a price target of $6.00. The company’s shares closed last Tuesday at $0.81, close to its 52-week low of $0.75.
According to TipRanks.com, Blum is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on Avrobio is a Moderate Buy with an average price target of $4.50, which is a 439.9% upside from current levels. In a report issued on May 10, Mizuho Securities also maintained a Buy rating on the stock with a $6.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PTN:
